A2DMQY Cronos Group Inc

Cronos Brand Spinach® Celebrates Summer with New Launches

Cronos Brand Spinach® Celebrates Summer with New Launches

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) Spinach® brand is expanding its portfolio of award-winning and best-selling cannabis products just in time for the summer months. Summer innovations feature new flavors and formats from Cronos’ SOURZ by Spinach® edibles and a premier milled flower product.

The new SOURZ by Spinach® Fully Blasted gummies offer the same great-tasting SOURZ by Spinach® flavors, now with 10 mg of THC per piece. The SOURZ by Spinach® Tropical Party Pack introduces new gummies with bolder tropical flavors, in the distinctive Spinach® “S” shape. These gummies have a perfect blend of sour and sweet and utilize Cronos' proprietary flavor-masking technology.

SOURZ by Spinach® Fully Blasted includes one 10 mg THC gummy per package in the following flavors:

  • Pink Lemonade
    • Sweet and refreshing flavors of raspberry and lemonade
  • Blue Raspberry Watermelon
    • Electric blue raspberry and refreshing watermelon
  • Cherry Lime
    • Delightful cherry and tangy lime

SOURZ by Spinach® Tropical Party Pack:

  • 1 mg THC per gummy, 10 mg THC per pack
  • Featuring three new dual-flavors: Peach Passionfruit, Pineapple Coconut, and Strawberry Guava

Additionally, the Spinach® brand will introduce Spinach Grindz™, milled flower options designed to be ready to use for joints or vaporizers. Ready-to-use milled flower offerings have grown in popularity in the Canadian cannabis market, appealing to value-conscious consumers seeking convenience. Spinach Grindz™ caters to this growing demand by providing high-quality, milled cannabis that saves time and effort, allowing consumers to enjoy a consistent and hassle-free cannabis experience.

Spinach Grindz™ are now available in the following strains:

  • Citrus Crush
    • Milled flower with citrus, sour, and earthy notes
  • Cookie Dough
    • Milled flower with sweet, nutty, and creamy notes

“We are thrilled to introduce these exciting new products under our Spinach® brand just in time for summer,” said Mike Gorenstein, Chairman, President, and CEO of Cronos Group. “Our goal is to continually innovate and provide our adult consumers with high-quality, enjoyable cannabis experiences. With these new products from our best-selling Spinach® brand featuring vibrant new flavors and sought-after strains, we believe there’s something for everyone this summer season.”

For more information and regional availability, visit .

About Cronos Group Inc. 

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements 

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about anticipated product launches, the timing of such launches and the availability of such products; consumer reception with respect to new product launches; the consumer experience with respect to new product launches; continual product innovation; and Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, each of which has been filed on SEDAR+ and EDGAR and can be accessed at and /edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

For further information, please contact: 

Investor Relations Contact: 

Shayne Laidlaw 

Investor Relations 

Tel: (416) 504-0004 

 

Media Relations Contact: 

Emily Whalen 

Communications 

Tel: (416) 504-0004 



EN
27/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos Grows its International Footprint in Switzerland

Cronos Grows its International Footprint in Switzerland TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training. “We are excited to partner with Dascoli to bring high-quality medical cannabis to Swiss patients,” said Mike Gorenstein, Chairman, ...

 PRESS RELEASE

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Sharehol...

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was...

 PRESS RELEASE

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Co...

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST. A live webcast will be available on the Investors section of the Company’s website at . About Cronos Group Inc.Cronos is an innovative global cannabinoid company...

 PRESS RELEASE

Cronos Group Reports 2025 First Quarter Results

Cronos Group Reports 2025 First Quarter Results Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Industry-leading balance sheet with $838 million in total cash and cash equivalents and short-term investments TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 first quarter business results. "2025 is shaping up to be a transformative yea...

 PRESS RELEASE

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2025 Annual Meeting online regardless of their geographic location, including a chance to ask questions and vote. Th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch